Karnofsky Performance Status

"Karnofsky Performance Status" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.

Descriptor ID	D017567
MeSH Number(s)	E05.318.308.980.438.475.456.500.500 N05.715.360.300.800.438.375.364.500.500 N06.850.520.308.980.438.475.364.500.500
Concept/Terms	Karnofsky Performance Status Karnofsky Performance Status Performance Status, Karnofsky Status, Karnofsky Performance Karnofsky Performance Status Scale Karnofsky Scale Scale, Karnofsky Karnofsky Index Index, Karnofsky

Below are MeSH descriptors whose meaning is more general than "Karnofsky Performance Status".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Surveys and Questionnaires [E05.318.308.980]
Health Surveys [E05.318.308.980.438]
Health Status Indicators [E05.318.308.980.438.475]
Patient Acuity [E05.318.308.980.438.475.456]
Severity of Illness Index [E05.318.308.980.438.475.456.500]
Karnofsky Performance Status [E05.318.308.980.438.475.456.500.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Surveys and Questionnaires [N05.715.360.300.800]
Health Surveys [N05.715.360.300.800.438]
Health Status Indicators [N05.715.360.300.800.438.375]
Patient Acuity [N05.715.360.300.800.438.375.364]
Severity of Illness Index [N05.715.360.300.800.438.375.364.500]
Karnofsky Performance Status [N05.715.360.300.800.438.375.364.500.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Surveys and Questionnaires [N06.850.520.308.980]
Health Surveys [N06.850.520.308.980.438]
Health Status Indicators [N06.850.520.308.980.438.475]
Patient Acuity [N06.850.520.308.980.438.475.364]
Severity of Illness Index [N06.850.520.308.980.438.475.364.500]
Karnofsky Performance Status [N06.850.520.308.980.438.475.364.500.500]

Below are MeSH descriptors whose meaning is related to "Karnofsky Performance Status".

Below are MeSH descriptors whose meaning is more specific than "Karnofsky Performance Status".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Karnofsky Performance Status" by people in this website by year, and whether "Karnofsky Performance Status" was a major or minor topic of these publications.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 2 publications in 2015 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2005	1	0	1
2015	0	2	2
2018	1	0	1
2019	1	0	1
2020	0	2	2

Below are the most recent publications written about "Karnofsky Performance Status" by people in Profiles.

Avis NE, Levine B, Goyal N, Crawford SL, Hess R, Colvin A, Bromberger JT, Greendale GA. Health-related quality of life among breast cancer survivors and noncancer controls over 10 years: Pink SWAN. Cancer. 2020 05 15; 126(10):2296-2304.

View in: PubMed
Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, López-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Lancet Gastroenterol Hepatol. 2020 03; 5(3):285-294.

View in: PubMed
Li S, Natwick T, Liu J, Morrison VA, Vidito S, Werther W, Yusuf AA, Usmani SZ. Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States. J Geriatr Oncol. 2019 05; 10(3):490-496.

View in: PubMed
Dolgin NH, Smith AJ, Harrington SG, Movahedi B, Martins PNA, Bozorgzadeh A. Association Between Sarcopenia and Functional Status in Liver Transplant Patients. Exp Clin Transplant. 2019 10; 17(5):653-664.

View in: PubMed
D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015 Nov 10; 33(32):3741-9.

View in: PubMed
Liu Y, Alexander BM, Chen YH, Horvath MC, Aizer AA, Claus EB, Dunn IF, Golby AJ, Johnson MD, Friesen S, Mannarino EG, Wagar M, Hacker FL, Arvold ND. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol. 2015 Sep; 124(3):429-37.

View in: PubMed
Cohen LM, Ruthazer R, Germain MJ. Increasing hospice services for elderly patients maintained with hemodialysis. J Palliat Med. 2010 Jul; 13(7):847-54.

View in: PubMed
Tzortzidis F, Elahi F, Wright DC, Temkin N, Natarajan SK, Sekhar LN. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas. Neurosurgery. 2006 Jun; 58(6):1090-8; discussion 1090-8.

View in: PubMed
Polin RS, Marko NF, Ammerman MD, Shaffrey ME, Huang W, Anderson FA, Caputy AJ, Laws ER. Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres. J Neurosurg. 2005 Feb; 102(2):276-83.

View in: PubMed
Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996; 12(1):5-11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals